琥珀酰化
下调和上调
调节器
细胞生物学
线粒体
化学
心功能曲线
功能(生物学)
心脏功能不全
运输机
药理学
微阵列分析技术
谷胱甘肽
生物
自噬
溶质载体族
基质(水族馆)
线粒体内膜
脂锚定蛋白
炎症
作者
Xin Li,Rong Huang,Zaixiao Tao,Rui Zhang,纪振军,Ya Hu,Yang Xu,Rui Sun,Yongjun Li,Genshan Ma
标识
DOI:10.1038/s41419-026-09222-x
摘要
Abstract Protein succinylation is increasingly recognized for its pivotal role in cardiovascular pathophysiology, yet the specific function of succinyl-CoA:3-ketoacid CoA transferase 1 (OXCT1) in myocardial ischemia/reperfusion (I/R) injury remains to be fully elucidated. In this study, we identify OXCT1 as a critical anti-ferroptotic regulator that protects the myocardium against I/R-induced damage. Using cardiomyocyte-specific OXCT1 ablation and overexpression mouse models, we observed that while OXCT1 expression is significantly upregulated following I/R injury, its deficiency exacerbates cardiac dysfunction and ferroptosis, whereas its replenishment confers robust cardioprotection. Mechanistically, through RNA-seq and co-immunoprecipitation followed by mass spectrometry (IP/MS), we identified the mitochondrial glutathione (GSH) transporter SLC25A11 as a direct interacting partner and succinylation substrate of OXCT1. We demonstrate that OXCT1 mediates the succinylation of SLC25A11 at the K256 residue, which competitively inhibits its ubiquitination-mediated degradation. The resulting stabilization of SLC25A11 is essential for maintaining mitochondrial GSH homeostasis, thereby suppressing cardiomyocyte ferroptosis and mitigating I/R injury. Our findings reveal a novel molecular switch involving OXCT1-mediated succinylation and suggest that targeting the OXCT1-SLC25A11 axis represents a promising therapeutic strategy for minimizing cardiac dysfunction following I/R injury.
科研通智能强力驱动
Strongly Powered by AbleSci AI